Markel CEO May Be Absent for Two Months for Treatment
Stock Chart for Markel Corp (MKL)
Kirshner should return to work in February, he said today in a statement distributed by PR Newswire. The statement didn’t give details on Kirshner’s medical treatment.
“For the next 60 days he’s going to be dealing with a procedure that will render him less accessible than he would otherwise be,” Bruce Kay, a spokesman for Markel, said in a telephone interview today. “It’s not emergency surgery.”
To contact the editor responsible for this story: Dan Kraut in New York at firstname.lastname@example.org
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.